Introduction: To characterize extended-spectrum β-lactamases (ESBLs) and plasmid-mediated quinolone resistance (PMQR) genes in Escherichia coli isolates obtained from extra-intestinal samples in three Uruguayan hospitals. Methodology: Fifty-five ESBL-producing E. coli isolates were studied. Virulence genes, ESBLs, and PMQR genes were detected by polymerase chain reaction. ESBL-producing isolates were compared by pulsed-field gel electrophoresis. Multi-locus sequence typing was also performed on 13 selected isolates. Results: Thirty-seven isolates harbored bla CTX-M-15 (67.3%), eight bla CTX-M-2 (14.6%), five bla CTX-M-14 (9.1%), three carried both bla CTX-M-2 and bla CTX-M-14 , one bla CTX-M-9 , and one bla CTX-M-8 . Among the CTX-M-15 producers, 92% belonged to sequence types ST131 and ST405, and carried aac(6')Ib-cr as well. Isolates harboring bla CTX-M-2 , bla CTX-M-14 , bla CTX-M-9 , or bla CTX-M-8 were found to be genetically unrelated. Conclusions: The successful dissemination of CTX-M-15-producing E.coli isolates seems to be linked to the spreading of high-risk clones and horizontal gene transfer. A trade-off between carrying more antibiotic resistance and less virulence-related genes could partially account for the evolutionary advantages featured by successful clones.
Introduction
Escherichia coli is a versatile pathogen, responsible for intestinal and extra-intestinal infections. Urinary tract infections (UTIs), sepsis, bacteremia, and meningitis are among the latter. The ability of E. coli to cause extra intestinal infections relies on a number of virulence factors that include adhesins, tissue-damaging effectors, and factors conferring resistance to the bactericidal activity of serum, among others [1, 2] .
Identification of extra-intestinal pathogenic E. coli strains (ExPEC) can be achieved by detecting at least two of the following genes: papA, papC, sfa/foc, afa/dra, iutA, or kpsM II [3] . The occurrence of these genes is associated with strains belonging to phylogenetic groups B2 and D (associated with ExPEC), and less frequently with groups A and B1, corresponding to commensal E. coli strains [4] .
The emergence of successful clones such as E. coli ST131 or clonal group A (CGA), both distributed worldwide, is a clear example of coexistence between antibiotic multiresistance and virulence factors [5] [6] [7] .
Co-resistance in E. coli to oxyiminocephalosporins (especially mediated by ESBLs) and quinolones is an increasing event worldwide, particularly in Latin America [8] . Yet, the available information concerning the dissemination of different clones and/or the presence of virulence factors is scarce in South America [9, 10] .
In Uruguay, the occurrence of E. coli strains producing PER-2, CTX-M-15, SHV-5, or CTX-M-2 ESBLs, as well as plasmid-mediated quinolone resistance genes (PMQR) linked to CTX-M-15, has already been reported [11] [12] [13] [14] . We recently issued the first report in Latin America of a non-ExPEC strain harboring CTX-M-19 [15] ; nevertheless there is no information so far that relates virulence factors in ExPEC, ESBLs, and PMQR among the circulating clones.
In the present work, we describe the ESBLs present in E. coli strains obtained from extra-intestinal samples from three hospitals in Uruguay.
Methodology

Bacterial isolates
Fifty-five ESBL-producing extra-intestinal E. coli isolates were obtained from three Uruguayan hospitals located in two different cities, between 1 March 2010 and 28 February 2011. Each isolate was designated with letters E, C, or HP according to the hospital of origin. Thirty-six isolates were recovered from urine, seven from blood, five from skin lesions, two from abscesses, three from respiratory samples, and two from peritoneal fluid samples.
Antimicrobial susceptibility and detection of extendedspectrum β-lactamases (ESBLs)
Bacterial identification and antibiotic susceptibility tests were performed using the VITEK2 Compact system (bioMérieux, Marcy l'Étoile, France). Every isolate displaying minimum inhibitory concentration (MIC) values to cefotaxime and/or ceftazidme and/or cepefime > 1 µg/mL underwent ESBL screening and confirmatory tests using ceftazidime and cefotaxime (30 µg) alone and combined with 10 µg of clavulanate, performed by disk diffusion as suggested by Clinical Laboratory Standards Institute (CLSI) guidelines [16] . MIC values to ceftazidime, cefotaxime, and ciprofloxacin were confirmed by Etest (bioMérieux, Marcy l'Étoile, France), following the manufacturer's instructions.
Characterization of ESBL and PMQR genes
Isolates with positive ESBL-screening results were further analyzed by polymerase chain reaction (PCR) for the presence of bla CTX-M , bla TEM , bla PER-2 , and bla SHV genes using specific primers [11] ; PCR products were sequenced on both strands using the same primers.
The occurrence of genes qnrA, qnrB, qnrC, qnrD, qnrS, and qepA was also screened by PCR, in isolates with MIC to nalidixic acid > 2 µg/mL [11] . Strains displaying MIC values to amikacin > 2 µg/mL were analyzed for the presence of aac(6′)Ib and the cr variant [11] .
Multi-locus sequence typing (MLST), determination of CGA, and PFGE
MLST was performed on selected isolates, representative of the most frequent pulsetypes, by gene amplification and sequencing of seven housekeeping genes (adk, fumC, gyrB, icd, mdh, purA, and recA), according to the protocol and primers specified at the E. coli MLST web site (http://mlst.ucc.ie/mlst/dbs/Ecoli).
XbaI PFGE analysis was performed as previously described [17] . Additionally, CGA was determined for isolates characterized by MLST and belonging to phylogenetic group D by single-nucleotide polymorphisms (SNPs) analysis of fumC, as described by Johnson et al. [18] . PFGE profiles were analyzed with BioNumerics fingerprinting software (Applied Maths, St-Martens-Latem, Belgium). Dendrograms were generated using the unweighted pair-group method (UPGMA) using arithmetic averages, based on the Dice similarity coefficient, with a 2.0% band position tolerance. PFGE profiles sharing > 85% similarity were considered to be genetically related [19] .
Transfer of ESBL, conjugation assays, and plasmid characterisation
Twenty-five isolates representative of all pulsetypes were selected for conjugation and plasmid characterization. Conjugation assays were carried out using rifampicin-resistant E. coli J53-2 strain as recipient. Transconjugants were selected on MacConkey agar plates (Oxoid, Basingstoke, UK) supplemented with rifampicin (150 mg/L) (SigmaAldrich St. Louis, USA) and ceftriaxone (1 mg/L) (Sigma-Aldrich St. Louis, USA) [20] .
Conjugative plasmid incompatibility groups (Inc) and addiction systems were determined by PCR-based replicon-typing according to Carattoli et al. and Mnif et al., respectively, using genomic DNA obtained from transconjugants as a template [21, 22] .
Phylogenetic group and virulotyping
Classification of isolates into phylogenetic groups was determined by PCR as previously described [4] , based on the presence or absence of three DNA fragments: chuA-, yjaA, and Tspe4.C2. Additionally, the sub-grouping scheme proposed by Branger et al. [23] was used. Briefly, the absence of the three DNA fragments corresponds to subgroup A 0 , whereas the occurrence of only yjaA corresponds to A 1 ; on the other hand, B2 2 corresponds to the occurrence of chuA and yjaA, and B2 3 is defined by the presence of the three DNA fragments. Finally, subgroup D 1 features the presence of only chuA, whereas subgroup D 2 features chuA and Tspe4.C2.
Detection of virulence-related genes was performed in two stages. First, all isolates underwent PCR virulence screening (VS) as previously described by Johnson et al [3] .
Next, isolates carrying two or more of papA, papC, sfa/foc, afa/dra, iutA, or kpsM II genes (i.e., VS+) were further examined by multiplex PCR for another 25 virulence-related genes, as described by Johnson et al. [1] .
Results
The 55 isolates under study were phenotypically identified as ESBL-producers; however, the proportion of isolates resistant to cefotaxime or to ceftazidime was dissimilar.
According to the CLSI interpretative criteria, 100% of the isolates were resistant to cefotaxime (MIC50 = 64 µg/mL, MIC90 ≥ 256 µg/mL), whereas only 40% (22) were resistant to ceftazidime (MIC50 = 2 µg/mL, MIC90 = 32 µg/mL). On the other hand, 50/55 (90.9%) were resistant to ciprofloxacin ( Figure  1 , Table 1 ).
The 55 ESBL-producing isolates were distributed in 12 different resistance patterns; (Table 1) nevertheless, 39/55 (70.9%) were clustered in three major profiles ( Table 1) .
All of the isolates were susceptible to carbapenems (data not shown). 
Detection of ESBLs and transferable quinolone resistance
A total of 58 ESBL genes were detected among the 55 ESBL-producing isolates. Thirty-seven isolates (67.3%) carried bla CTX-M-15 , eight (14.6%) carried bla CTX-M-2 , five (9.1%) carried bla CTX-M-14 , three carried both bla CTX-M-2 and bla CTX-M-14 (isolates C54, C66, and E69), one isolate carried bla CTX-M-8 , and another single isolate carried bla CTX-M-9 ( Figure 1 ). Conversely, no bla TEM , bla SHV , or bla PER-2 ESBL genes were detected.
Fifty of the ESBL-producing isolates were also resistant to ciprofloxacin, 35 of which harbored aac(6')Ib-cr (33 carried bla CTX-M-15 and two carried bla CTX-M-14 ). Additionally, qnrA was detected in a single isolate, along with bla CTX-M-9 . Furthermore, qnrB was detected along with bla CTX-M-8 ; however, in both cases, MIC values to ciprofloxacin were within the susceptibility range defined by the CLSI ( Figure  1 ). No qnrC, qnrD, qnrS, or qepA genes were detected.
Clonal relationship
PFGE assays were performed on all ESBLproducing isolates; four of them were untypeable (three CTX-M-2 producers and one CTX-M-15 producer).
PFGE analysis of bla CTX-M-15-bearing isolates indicated that they were clustered in five pulsetypes; two major pulsetypes, named A and B, accounted for 20 and 13 isolates, respectively, whereas pulsetypes C and D comprised two isolates each, and pulsetype E included a single isolate (Figure 2) .
On the other hand, isolates carrying bla CTX-M-2 , bla CTX-M-14 , bla CTX-M-9 , and bla CTX-M-8 belonged to different pulsetypes, named F through O (Figure 2) .
MLST analysis showed that all of the isolates in pulsetype A belonged to sequence type ST131, whereas isolates in pulsetype B belonged to ST405.
Isolates belonging to ST131 were detected in the three hospitals included in this study and were recovered from various sources (urine, blood, surgical wound infections, and peritoneal fluid).
Similarly, isolates belonging to ST405 were only recovered in two hospitals (both located in the capital city, Montevideo) from similar sources, including broncheoalveolar lavage, abscesses, and pleural fluid as well. (6) , A/131/CTX-M-15 (1) , K/ND/CTX-M-2 (1) , LL/ND/CTX-M-2,CTX-M-14 (1) , NT/ND/CTX-M-2 (1) , N/ND/CTX-M-14 (1) , D/ND/CTX-M-14 (3) , A/131/CTX-M-15 (6) , NT/ND/CTX-M-2 (2) , C/ND/CTX-M-15 (1) , I/ND/CTX-M-2 (1) , G/ND/CTX-M-14 (1) , H/ND/CTX-M-14
11
O: oxyiminocephalosporins; Ak: amikacin; G: gentamicin; N: nalidixic acid; C: ciprofloxacin; S: sulfamethoxazole-trimethoprim; PT: pulsetype; ST: sequence type; N: number of isolates displaying each resistance profile, (n) number of isolates belonging to each clone within a particular resistance profile. 
Characters in boldface correspond to the only sequence type compatible with CGA, according to the SNP profile.
On the other hand, CTX-M-2-producing isolates were typed as ST393 (n = 2), ST38, ST1158, and ST3627, whereas CTX-M-9 and CTX-M-8-producing isolates were found to belong to ST69 and ST3555, respectively.
Determination of clonal group A
Phylogenetic group D included 21 isolates, 13 of which belonged to pulsetype B and ST405. Furthermore, another 6 isolates underwent MLST studies. Sequence analyses of fumC aimed at the detection of CGA showed that only a single isolate (HP21), belonging to ST69 and carrying bla CTX-M-9 /qnrA, displayed the SNP C288T ( Table 2) .
Transfer of ESBL genes and plasmid characterization
Twenty-five isolates representative of each pulsetype, as well as the four untypeable isolates, were selected for conjugation assays: seven isolates harboring bla CTX-M-15 , eight bla CTX-M-2 , five bla CTX-M-14 , three isolates carrying both bla CTX-M-2 and bla CTX-M-14 , one carrying bla CTX-M-9 , and one with bla CTX-M-8 (Table  3 ). Thirteen transconjugants were obtained. All of the bla CTX-M-14 , bla CTX-M-9 , and bla CTX-M-8 genes were encoded in conjugative plasmids; however, only two bla CTX-M-15 alleles (carried by isolates E13 and E20, pulsetypes A and C, respectively) as well as a single bla CTX-M-2 allele (isolate E44, pulsetype K) were encoded in conjugative plasmids.
Seven of the bla CTX-M-14 alleles were encoded in IncI1 plasmids featuring a pndAC addiction system. In contrast, plasmids carrying bla CTX-M-2 (IncF-FIB, IncA/C) and bla CTX-M-9 (IncHI1-HI2) featured no addiction systems. Nevertheless, both of the bla CTX-M-15 -bearing plasmids featured several addiction systems, specifically vagCD, pemKI, ccdAB, and srnBC (Table  3) .
Phylogenetic group and virulotyping of ESBLproducing strains
Forty-one of the 55 ESBL-producing isolates belonged to phylogenetic groups B2 and D (B2 3 = 20; D 2 = 13; D 1 = 8). However, only 29 of such isolates were VS+, namely the twenty strains belonging to phylogenetic group B2 3 (pulsetype A, ST131, CTX-M-15 producers), eight isolates belonging to phylogenetic group D 1 , and one isolate belonging to phylogenetic group A 1 (Figure 1) .
Isolates belonging to phylogenetic group D 1 were found to be genetically unrelated; five such isolates were CTX-M-2 producers and were typed as ST393 (n = 2), ST38, ST1158, and ST3627. Other D 1 isolates included a CTX-M-9 and QnrA-producer (ST69), as well as another isolate belonging to the new sequence type ST3555, which harbored both qnrB and bla CTX-M- 8 .
Isolates carrying large numbers of virulence genes (between 9 and 10), namely isolates E38, E69, and HP21, belonged to phylogenetic group D 1 ; nevertheless, they were not among the most disseminated strains.
On the other hand, the 14 isolates belonging to phylogenetic group D 2 and ST405 were VS-.
Discussion
In the present study, the 55 ESBL-producing isolates were distributed in 12 different resistance patterns, the most frequent being oxyiminocephalosporins / nalidixic acid / ciprofloxacin / sulfamethoxazole-trimethoprim (n = 15), oxyiminocephalosporins / gentamicin / nalidixic acid / ciprofloxacin / sulfamethoxazole-trimethoprim (n = 12), and oxyiminocephalosporins / amikacin / nalidixic acid / ciprofloxacin / sulfamethoxazoletrimethoprim (n = 12).
Co-resistance to fluoroquinolones was observed in 90.9% (50/55) of the studied isolates; co-resistance to sulfamethoxazole trimethoprim was detected in 85.5% (47/55), co-resistance to gentamicin in 41.8% (23/55), and co-resistance to amikacin in 34.5% (19/55) .
Recent studies have reported susceptibility results and molecular characterization of E. coli isolates in India, albeit with some differences; while coresistance levels to sulfamethoxazole-trimethoprim and to ciprofloxacin were similar (81.6% and 93.9%, respectively), co-resistance to amikacin was higher (57.1%), and resistance to carbapenems was even detected (20.4%) [24] .
Sixty percent of the isolates (33/55) were clustered in two clones, namely B2 3 -ST131 and D 2 -ST405. Accordingly, these clones accounted for 56.5% of coresistance to gentamicin (13/23 isolates) and 66% of co-resistance to ciprofloxacin (33/50); however, they were responsible for 84.2% of co-resistance to amikacin (16/19 isolates).
Although both clones have been widely reported worldwide [25] [26] [27] [28] , their presence in South America is still scarcely reported [9, 10, 29] .
In the present study, 41/55 isolates (74.5%) corresponded to phylogenetic groups B2 and D; nevertheless, only 28 (50.9%) could be classified as ExPEC based on VS. Additionally, all of the isolates corresponding to phylogenetic group B2 belonged to ST131. Our results are in accordance with those of Brisse et al., who found that CTX-M-production in ExPEC was exceptional in non-ST131 B2 strains [30] . Conversely, Roy et al. recently reported that over a third of CTX-M-15-producing E. coli B2 strains did not belong to ST131 [24] . These discrepancies highlight the importance of knowing the local epidemiology, in order to determine the circulating clones in each region.
Multiresistant clone B2 3 -ST131 has been previously associated with a high number of virulence genes [27, 31] ; in this work, the number of virulence genes associated with this clone was between five and eight. Regarding the clone D 2 -ST405, none of the antibiotic-resistant isolates could be classified as ExPEC (based on VS). Conversely, only a single isolate belonging to CGA was detected, which suggests that this group does not constitute a problem, at least within the studied hospitals. This isolate, however, harbored a large number (10) of virulencerelated genes. Accordingly, this ST69 isolate (HP21) along with isolates E38 and E69 (ST393 and ST38, respectively) carried large numbers of virulence genes and were not disseminated.
In this sense, the multiresistant clone B2 3 -ST131 could have reached an optimal balance between virulence and antibiotic resistance, allowing it to competitively colonize, to cause infection, and to disseminate among different hosts.
On the other hand, we recently reported that a group of non-ExPEC E. coli isolates (based on VS) formed intracellular niches in urothelial cells; this finding was linked to the occurrence or recurrent UTIs [32] . Taking those findings into consideration, it is possible that the diversity of virulence-related genes in ExPEC is greater than the VS employed during the present study.
With respect to ESBL production, this is the first study to show a clear predominance in our region of CTX-M-15 in E. coli strains (60%), followed by CTX-M-2 (20%). Until recently, and particularly in Uruguay, the most frequently detected ESBL (in varying proportions) was CTX-M-2 [12, 33] . CTX-M-15 was first detected in 2006 in a general hospital [13] , and in 2009, this ESBL was detected in the pediatric hospital [11] . However, until now, there was no information on the sequence types of ESBL-producing E. coli strains. The presence of CTX-M-15-producing pandemic clones such as ST131 and ST405 has already been reported in Colombia [10] and Argentina (ST131) [9] ; nevertheless, there is no information about the sequence types associated with other CTX-M enzymes in our continent.
The CTX-M-9 and QnrA1-producing strain was typed as ST69, which has already been associated with ESBL and non-ESBL-producing strains [34, 35] . In our study, this was the only isolate that belonged to CGA. Strains belonging to CGA have been widely reported around the world, even in South America [7, 18] ; nevertheless, in general, there is no information regarding sequence types of CGA strains.
On the other hand, CTX-M-2-producing strains were associated with various sequence types, which included clones already linked to CTX-M enzymes such as ST38 and ST393 [25, [34] [35] [36] . Furthermore, CTX-M-2 was detected in clones so far unrelated with antibiotic resistance, i.e., ST1158 (allelic profile 18, 3, 17, 6, 5, 5, 4) and in the novel sequence type ST3627 (allelic profile 13, 26, 39, 25, 5, 31, 19) . Additionally, the isolate carrying qnrB/bla CTX-M-8 also belonged to the novel sequence type ST3555 (allelic profile 101, 19, 97, 108, 26, 79, 19) .
CTX-M-8 was first described in Brazil in 2000, but was only recently detected in other South American countries including Uruguay and Argentina [9, 11] . Additionally, this ESBL seems to be slowly disseminating in Europe, Africa, and Asia as well [37] [38] [39] .
In our country, the dissemination of CTX-M-15 may be the result of two mechanisms: either the dispersion of successful clones such as ST131 and ST405, or the acquisition of conjugative plasmids featuring multiple addiction systems.
On the other hand, the expansion of bla CTX-M-14 could be mainly due to cross-species dissemination of IncI1 plasmids featuring the pndAC addiction system. In this regard, we recently reported the occurrence of bla CTX-M-14 in an isolate of Salmonella enterica serovar Enteritidis, encoded in a similar plasmid [40] . Additionally, in our continent, IncI1 plasmids harboring bla CTX-M-14 and bla CTX-M-19 (both belonging to group 4 in the CTX-M family) have already been described in E. coli strains in our country and in Bolivia [14, 36] .
Furthermore, only one of the 11 isolates encoding bla CTX-M-2 carried such gene in a conjugative plasmid. Incidentally, such plasmid had no addiction systems.
Recently, Bartoloni et al., in a 20-year study, reported a shift in the epidemiology of ESBLs in Bolivia and Perú, describing an increase in the prevalence of CTX-M-15 and CTX-M-14, and a decrease of CTX-M-2 [41] . A similar scenario was also described in Argentina [9] .
Conclusions
In this study, we propose some elements that could account for this epidemiologic change. For instance, the association of CTX-M-15 with successful clones or with plasmids carrying addiction systems, and/or the dissemination bla CTX-M-14 in conjugative IncI1 plasmids with pndAC, contrasts with the small proportion of bla CTX-M-2 -encoding conjugative plasmids lacking detectable addiction systems.
Additionally, the link between CTX-M-15 (which confers higher resistance levels to ceftazidime) and PMQR such as aac(6')Ib-cr, creates better chances for co-selection of those isolates carrying both resistance mechanisms, in relation to those carrying only CTX-M-2.
The fact that these changes in the epidemiology of ESBLs go hand in hand with changes in genes conferring resistance to other antimicrobials (such as PMQR) highlights the importance of molecular and epidemiological studies.
